BioCentury | Apr 15, 2017
Product Development

Outside factors

...of coagulation in healthy volunteers and hemophilia patients. Bayer has not yet published data on BAY 1093884...
...hematology at Bayer, said the pharma is still figuring out the dosing schedule, but that BAY 1093884...
BioCentury | Jul 16, 2015
Translation in Brief

Bayer's replacement antibody

...is far more convenient for patients. Last month, Bayer presented data on its lead compound, BAY 1093884...
...to identify which Kunitz domains would elicit the most effective antibodies, and produced the mAbs BAY 1093884...
...and BAY 1093889, which binds only K2. Using surface plasmon resonance, the team showed that BAY 1093884...
BioCentury | Jul 13, 2015
Clinical News

Bayer preclinical data

...In a mouse model of hemophilia A, single doses of 0.6-2 mg/kg IV BAY 1093884 given prior...
...for 1,000 IU/kg of recombinant Factor VIII. Additionally, a single 18 mg/kg dose of IV BAY 1093884...
...for recombinant Factor VIII. In a rabbit model of hemophilia A, 1 and 3 mg/kg BAY 1093884...
Items per page:
1 - 3 of 3